antipsychotic agents and lithium

84
Antipsychotic Agents & Lithium By M.H.Farjoo M.D. , Ph.D. Shahid Beheshti University of Medical Science

Upload: mohammad-hadi-farjoo-md-phd

Post on 06-May-2015

2.794 views

Category:

Health & Medicine


8 download

DESCRIPTION

The underlined words are hyperlinks; please click on them to see the whole presentation.Please tell me what you think about my slides, you can write to: [email protected]

TRANSCRIPT

Page 1: Antipsychotic agents and lithium

Antipsychotic Agents &

Lithium

By

M.H.Farjoo M.D. , Ph.D.Shahid Beheshti University of Medical Science

Page 2: Antipsychotic agents and lithium

Antipsychotic Agents & Lithium

Introduction

Dopamine Hypothesis

Dopaminergic Systems

Antipsychotic Drugs

Classification

Clinical Application

Adverse Effects

Overdose

Drug Choice

Mania Lithium

Mechanism of Action Clinical Application Adverse Effects Special Issues

Newer drugs Drug Pictures

Page 3: Antipsychotic agents and lithium
Page 4: Antipsychotic agents and lithium
Page 5: Antipsychotic agents and lithium
Page 6: Antipsychotic agents and lithium

Depression

ManiaPsychosis

Page 7: Antipsychotic agents and lithium

Introduction to Schizophrenia

Schizophrenia remains a scientific mystery and a personal disaster.

Many patients show little response and virtually none show a complete response.

The psychosis produced by phencyclidine (PCP) has been used as a model for schizophrenia.

This drug is an antagonist of the NMDA glutamate receptor.

Page 8: Antipsychotic agents and lithium

M.H.Farjoo

Dopamine Hypothesis Most antipsychotic drugs strongly block dopamine

receptors (D2) in the CNS.

Increase in dopaminergic activity aggravates schizophrenia.

Dopamine receptors are increased in the brains of schizophrenics who have not been treated.

Dopamine receptor density in both treated and untreated schizophrenics is more than nonschizophrenics.

Successful treatment of schizophrenics changes the amount of homovanillic acid, a metabolite of dopamine.

Page 9: Antipsychotic agents and lithium

M.H.Farjoo

Dopamine Hypothesis cont,d

The dopamine hypothesis is far from complete. Antipsychotic drugs are only partially effective for

most and ineffective for some patients. Antagonists of NMDA (phencyclidine) produce

more schizophrenic symptoms than do dopamine agonists.

New antipsychotics (clozapine, olanzapine, and aripiprazole) have much less effect on D2 receptors.

Most of the newer "atypical" antipsychotics have significant inhibitory effect on the 5-HT2 receptor.

Page 10: Antipsychotic agents and lithium

Dopamine receptor type

D1 family D1 & D5 ↑cAMP Dilates renal blood vessels

D2 family D2 , D3 & D4 ↓ cAMP Modulates transmitter release

Page 11: Antipsychotic agents and lithium

Dopaminergic Systems

Mesolimbic-mesocortical pathway: most closely related to behavior.

Nigrostriatal pathway: it is involved in the coordination of voluntary movement.

Tuberoinfundibular system: physiologically inhibits prolactin secretion.

Medullary-periventricular pathway: may be involved in eating behavior.

Incertohypothalamic pathway: not well defined

Page 12: Antipsychotic agents and lithium

Antipsychotic Drugs

The antipsychotics block D2 receptors in the mesolimbic- mesocortical systems.

The therapeutic potency of antipsychotics does not correlate with their affinity for the D1 receptor but with D2 affinity.

The antagonism of dopamine in the nigrostriatal system explains the parkinsonism produced by these drugs.

The hyperprolactinemia is caused by blockade of dopamine's tonic inhibitory effect on prolactin release from the pituitary.

Page 13: Antipsychotic agents and lithium
Page 14: Antipsychotic agents and lithium
Page 15: Antipsychotic agents and lithium

M.H.Farjoo

Classification

Phenothiazines

Thioxanthene

Butyrophenone

Newer atypical drugs

ChlorpromazineThioridazineTrifluoprazinePerphenazineFluphenazine

Thiothixene

HaloperidolDroperidol

Pimozide ClozapineLoxapine OlanzapineRisperidoneAripiprazole

Page 16: Antipsychotic agents and lithium

M.H.Farjoo

Clinical Application

Schizophrenia.

Manic phase in bipolar disorders.

In combination with a TCA or SSRI in clearly depressed psychotic patient.

As antiemetics (except thioridazine).

Page 17: Antipsychotic agents and lithium

M.H.Farjoo

Adverse Effects

Pseudodepression

Extrapyramidal reactions.

Autonomic blocking effects.

Hyperprolactinemia

Toxic-confusional states

Agranulocytosis

Due to drug induced akinesiaTreated by antiparkinson drugs

Can induce infertility

Very high doses of drugs that have antimuscarinic actionsSeen with clozapine

Page 18: Antipsychotic agents and lithium

Extrapyramidal System

The extrapyramidal system is part of the motor system involved in the coordination of movement.

It is called "extrapyramidal" to distinguish it from the motor tracts traveling through the "pyramids" of the medulla.

The pyramidal pathways directly innervate motor neurons of the spinal cord.

The extrapyramidal system modulates and regulates anterior horn cells.

Page 19: Antipsychotic agents and lithium

Extrapyramidal Reactions

Extrapyramidal toxicity is associated with high D2 potency.

Extrapyramidal reactions include: Parkinson's syndrome: (diminished activity) Tardive dyskinesia: (increased activity) eg: choreo-

athetoid movements. Akathisia (uncontrollable restlessness) Dystonia, eg: spastic retrocollis or torticollis)

Page 20: Antipsychotic agents and lithium

Extrapyramidal Reactions Cont,d

Tardive dyskinesia, is the most important unwanted effect of antipsychotic drugs.

It is caused by a relative cholinergic deficiency secondary to supersensitivity of dopamine receptors

The first step is to reduce the antipsychotic or switch to one of the newer agents.

The second step is to eliminate all drugs with central anticholinergic action, particularly antiparkinsonism drugs and TCAs.

Page 21: Antipsychotic agents and lithium

M.H.Farjoo

Adverse Effects cont,d

Ocular complications Arrhythmia Neuroleptic malignant syndrome

Can be fatal in patients extremely sensitive to the extrapyramidal effects of

antipsychotics Muscle rigidity (lead pipe rigidity) Very high fever Leukocytosis BP & PR instability Elevated creatine kinase isozymes Treated by antiparkinson drugs & diazepam

Deposit in cornea & lens (chlorpromazine)Deposit in retina & browning of vision (thioridazine)

Thioridazine overdose can cause

sudden death

Confused with infection

Page 22: Antipsychotic agents and lithium

M.H.Farjoo

Overdose

Rarely is fatal, Except thioridazine. Gastric lavage should be done even if several

hours have elapsed. Manifested by:

Miosis Hypotension Hypothermia Drowsiness Agitation Coma

Responds to fluid replacement

Page 23: Antipsychotic agents and lithium

Drug Choice

The low cost of the older drugs contributes to their widespread use despite their clear side effects.

Newer antipsychotics (clozapine, risperidone, and olanzapine) show superiority over haloperidol.

The lower side effect of the newer agents and low risk of tardive dyskinesia makes them first line of treatment.

Page 24: Antipsychotic agents and lithium

Drug Choice Cont,d

The best guide for selecting a drug for an individual patient is the patient's past responses to drugs.

Within the older group, the trend has been toward the high-potency drugs (haloperidol).

Clozapine is limited to those who have failed to respond to conventional antipsychotic drugs.

Page 25: Antipsychotic agents and lithium

Drug Choice Cont,d

The agranulocytosis and seizures associated with this drug prevent more widespread use.

Risperidone's lower side effects have caused its widespread use.

Patients who fail to respond to one drug may respond to another; so several drugs should be tried.

Page 26: Antipsychotic agents and lithium
Page 27: Antipsychotic agents and lithium
Page 28: Antipsychotic agents and lithium
Page 29: Antipsychotic agents and lithium
Page 30: Antipsychotic agents and lithium

M.H.Farjoo

Lithium Mechanism of Action

Preponderance of catecholamine related activity is thought to be present.

The drug may decrease norepinephrine and dopamine turnover.

Post receptor effects. The prophylactic use of lithium can prevent

both mania and depression.

Page 31: Antipsychotic agents and lithium

Effect of lithium on the IP3 and DAG second-messenger system. The schematic diagram shows the synaptic membrane of a neuron. (PIP2, phosphatidylinositol-4,5-bisphosphate; PLC, phospholipase-C; G, coupling protein; EFFECTS, activation of protein kinase C, mobilization of intracellular Ca2+, etc.) Lithium, by inhibiting the recycling of inositol substrates, may cause depletion of the second-messenger source PIP2 and therefore reduce the release of IP3 and DAG. Lithium may also act by other mechanisms.

Page 32: Antipsychotic agents and lithium

M.H.Farjoo

Lithium Clinical Application

Bipolar Affective Disorder.

Schizoaffective disorders (a mixture of schizophrenia and depression).

Adjunct to antidepressants in major depression.

Page 33: Antipsychotic agents and lithium

M.H.Farjoo

Lithium Adverse Effects Tremor is very common and occurs in therapeutic

doses. Neurologic abnormalities: ataxia, aphasia and

confusion. Appearance of any new neurologic abnormality is a

clear indication for stopping treatment and TDM. Decreases thyroid function. Antagonizes ADH, resulting in nephrogenic diabetes

insipidus. The bradycardia-tachycardia ("sick sinus") syndrome is

a definite contraindication.

Page 34: Antipsychotic agents and lithium

M.H.Farjoo

Lithium Special Issues

Lithium serum concentration after delivery can rise to toxic concentrations

Lithium is found in breast milk, up to ½ that of serum

Page 35: Antipsychotic agents and lithium

M.H.Farjoo

Newer drugs Valproic acid (valproate):

Overall, it shows efficacy equivalent to that of lithium during the early weeks of treatment.

Valproic acid is effective in some patients who have failed to respond to lithium.

The mode of action of is unclear. Valproic acid is becoming recognized as a first-

line treatment for mania.

Page 36: Antipsychotic agents and lithium

M.H.Farjoo

Newer drugs (Cont’d)

Carbamazepine: The mode of action of is unclear. Carbamazepine has been considered to be a

reasonable alternative to lithium when the latter is less than optimally efficacious.

Carbamazepine may be used to treat acute mania and also for prophylactic therapy.

Overdoses are a major emergency and should be managed like overdoses of TCAs.

Page 37: Antipsychotic agents and lithium
Page 38: Antipsychotic agents and lithium
Page 39: Antipsychotic agents and lithium
Page 40: Antipsychotic agents and lithium
Page 41: Antipsychotic agents and lithium
Page 42: Antipsychotic agents and lithium
Page 43: Antipsychotic agents and lithium
Page 44: Antipsychotic agents and lithium
Page 45: Antipsychotic agents and lithium
Page 46: Antipsychotic agents and lithium
Page 47: Antipsychotic agents and lithium
Page 48: Antipsychotic agents and lithium
Page 49: Antipsychotic agents and lithium
Page 50: Antipsychotic agents and lithium
Page 51: Antipsychotic agents and lithium
Page 52: Antipsychotic agents and lithium
Page 53: Antipsychotic agents and lithium
Page 54: Antipsychotic agents and lithium
Page 55: Antipsychotic agents and lithium
Page 56: Antipsychotic agents and lithium
Page 57: Antipsychotic agents and lithium
Page 58: Antipsychotic agents and lithium
Page 59: Antipsychotic agents and lithium
Page 60: Antipsychotic agents and lithium
Page 61: Antipsychotic agents and lithium
Page 62: Antipsychotic agents and lithium
Page 63: Antipsychotic agents and lithium
Page 64: Antipsychotic agents and lithium
Page 65: Antipsychotic agents and lithium
Page 66: Antipsychotic agents and lithium
Page 67: Antipsychotic agents and lithium
Page 68: Antipsychotic agents and lithium
Page 69: Antipsychotic agents and lithium
Page 70: Antipsychotic agents and lithium
Page 71: Antipsychotic agents and lithium
Page 72: Antipsychotic agents and lithium
Page 73: Antipsychotic agents and lithium
Page 74: Antipsychotic agents and lithium
Page 75: Antipsychotic agents and lithium
Page 76: Antipsychotic agents and lithium
Page 77: Antipsychotic agents and lithium
Page 78: Antipsychotic agents and lithium

SummaryIn English

Page 79: Antipsychotic agents and lithium

Thank youAny question?

Page 80: Antipsychotic agents and lithium

Structural formulas of some older antipsychotic drugs: phenothiazines, thioxanthenes, and butyrophenones.

Page 81: Antipsychotic agents and lithium

Structural formulas of some newer antipsychotic drugs

Page 82: Antipsychotic agents and lithium

Antipsychotic drugs: Relation of chemical structure to potency and toxicities.

Chemical Class DrugD2/5-HT2A

Ratio1

Clinical Potency

Extrapyramidal Toxicity

Sedative Action

Hypotensive Actions

Phenothiazines            

  Aliphatic Chlorpromazine High Low Medium High High

  Piperazine Fluphenazine High High High Low Very low

Thioxanthene Thiothixene Very high High Medium Medium Medium

Butyrophenone Haloperidol Medium High Very high Low Very low

Dibenzodiazepine Clozapine Very low Medium Very low Low Medium

Benzisoxazole Risperidone Very low High Low2 Low Low

Thienobenzodiazepine Olanzapine Low High Very low Medium Low

Dibenzothiazepine Quetiapine Low Low Very low MediumLow to medium

Dihydroindolone Ziprasidone Low Medium Very low Low Very low

Dihydrocarbostyril Aripiprazole Medium High Very low Very low Low

1Ratio of affinity for D2 receptors to affinity for 5-HT2A receptors.2At dosages below 8 mg/d.

Page 83: Antipsychotic agents and lithium

Adverse pharmacologic effects of antipsychotic drugs.

Type Manifestations Mechanism

Autonomic nervous system

Loss of accommodation, dry mouth, difficulty urinating, constipation

Muscarinic cholinoceptor blockade

 Orthostatic hypotension, impotence, failure to ejaculate

Alpha adrenoceptor blockade

Central nervous system

Parkinson's syndrome, akathisia, dystonias

Dopamine receptor blockade

  Tardive dyskinesiaSupersensitivity of dopamine receptors

  Toxic-confusional state Muscarinic blockade

Endocrine system

Amenorrhea-galactorrhea, infertility, impotence

Dopamine receptor blockade resulting in hyperprolactinemia

Other Weight gainPossibly combined H1 and 5-HT2 blockade

Page 84: Antipsychotic agents and lithium

Dose relationships of antipsychotics.

 Minimum Effective Therapeutic Dose

(mg)

Usual Range of Daily Doses (mg)

Chlorpromazine (Thorazine) 100 100-1000

Thioridazine (Mellaril) 100 100-800

Trifluoperazine (Stelazine) 5 5-60

Perphenazine (Trilafon) 10 8-64

Fluphenazine (Permitil, Prolixin) 2 2-60

Thiothixene (Navane) 2 2-120Haloperidol (Haldol) 2 2-60Loxapine (Loxitane) 10 20-160

Molindone (Lidone, Moban) 10 20-200

Clozapine (Clozaril) 50 300-600

Olanzapine (Zyprexa) 5 10-30

Quetiapine (Seroquel) 150 150-800

Risperidone (Risperdal) 4 4-16

Ziprasidone (Zeldox) 40 80-160Aripiprazole (Abilify) 10 10-30